EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY-NC 4.0

Likely pathogenic variant in the BICD2 gene in fetus presenting with non‐immune hydrops

Natalie Chandler iD, Poppy Brace, Rowenna Roberts, Rhiannon Mellis iD

Prenatal Diagnosis · 2023

DOI: 10.1002/pd.6386 ↗

At a glance

Fallbericht in Prenatal Diagnosis, 2023. Written by Natalie Chandler and 3 co-authors. Institution: North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. Major MEDLINE topics: Microtubule-Associated Proteins, Muscular Atrophy, Spinal. Cited 2 times so far (Crossref); 4 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIHR Biomedical Research Centre, Great Ormond Street Hospital.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Trio exome sequencing was performed on a fetus presenting with severe hydrops fetalis at 21 + 0 weeks gestation. A novel de novo BICD2 missense variant was identified in the fetus. Pathogenic variants in the BICD2 gene are associated with lower extremity‐predominant spinal muscular atrophy. The variant was initially classified as a variant of uncertain clinical significance (VUS) as at the time of analysis and initial report, pathogenic variants in the BICD2 gene specifically had not been associated with fetal hydrops and no other abnormalities had been detected. It was agreed in multidisciplinary team discussions to include the variant in the report as a VUS recommending phenotypic follow‐up. The pregnancy was terminated and post‐mortem findings were in keeping with a BICD2 ‐pathogenic variant. In addition, a paper was published reporting another case with a pathogenic BICD2 variant presenting with fetal hydrops. The variant classification was then upgraded to class 4 likely pathogenic and reported as consistent with the diagnosis. This case demonstrates the importance of reporting these new gene/phenotypes in enabling others in the classification of variants, staying up‐to‐date with literature and following up phenotype for class 3 variants of interest.

Subjects

MeSH terms (MEDLINE)

Microtubule-Associated ProteinsMuscular Atrophy, SpinalHumansFemalePregnancyHydrops FetalisMutation, MissenseFetus

Substances

Microtubule-Associated ProteinsBICD2 protein, human

Authors and institutions

  • North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.

ORCID profiles: Natalie Chandler, Rhiannon Mellis

Funding

  • NIHR Biomedical Research Centre, Great Ormond Street Hospital

Cite

APA

Chandler, N., Brace, P., Roberts, R., & Mellis, R. (2023). Likely pathogenic variant in the BICD2 gene in fetus presenting with non‐immune hydrops. Prenatal Diagnosis. https://doi.org/10.1002/pd.6386

Vancouver

Chandler N, Brace P, Roberts R, Mellis R. Likely pathogenic variant in the BICD2 gene in fetus presenting with non‐immune hydrops. Prenatal Diagnosis. 2023. doi:10.1002/pd.6386

BibTeX
@article{Chandler2023,
  author = {Chandler, Natalie and Brace, Poppy and Roberts, Rowenna and Mellis, Rhiannon},
  title = {Likely pathogenic variant in the BICD2 gene in fetus presenting with non‐immune hydrops},
  journal = {Prenatal Diagnosis},
  year = {2023},
  doi = {10.1002/pd.6386}
}
Start for free →